Who owns iShares Genomics Immunology and Healthcare ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IDNA from SEC Form 13F filings across 67 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 67 institutions disclosed 2.5M shares of iShares Genomics Immunology and Healthcare ETF worth $84.7M — about 54.3% of shares outstanding; the largest disclosed holder is UBS Group AG. Source: SEC Form 13F filings, parsed by EvidInvest.
67
13F holders
$84.7M
value, 2026 filers
54.3%
of shares outstanding (2.5M sh)
14
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IDNA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | UBS Group AG | 493,571 | $16.7M | 0.0% | 10.5% | +1.4% |
| 2 | BANK OF AMERICA CORP /DE/ | 467,003 | $15.8M | 0.0% | 10% | +1.8% |
| 3 | Wharton Business Group, LLC | 268,472 | $9.1M | 0.3% | 5.7% | -0.6% |
| 4 | JANE STREET GROUP, LLCNEW | 114,932 | $3.9M | 0.0% | 2.5% | new |
| 5 | AMERIPRISE FINANCIAL INC | 111,053 | $3.7M | 0.0% | 2.4% | -2.9% |
| 6 | Portland Global Advisors LLC | 105,302 | $3.6M | 0.3% | 2.2% | +1.1% |
| 7 | WELLS FARGO & COMPANY/MN | 95,351 | $3.2M | 0.0% | 2% | +283.6% |
| 8 | Trek Financial, LLCNEW | 90,940 | $3.1M | 0.2% | 1.9% | new |
| 9 | ROYAL BANK OF CANADA | 88,543 | $3.0M | 0.0% | 1.9% | +70.8% |
| 10 | MORGAN STANLEY | 81,337 | $2.7M | 0.0% | 1.7% | -13.7% |
| 11 | RAYMOND JAMES FINANCIAL INC | 75,462 | $2.5M | 0.0% | 1.6% | -1.5% |
| 12 | LPL Financial LLC | 71,503 | $2.4M | 0.0% | 1.5% | -1.4% |
| 13 | Lido Advisors, LLC | 38,007 | $1.3M | 0.0% | 0.8% | +14.8% |
| 14 | Avior Wealth Management, LLC | 37,305 | $1.3M | 0.0% | 0.8% | +42.6% |
| 15 | Clearwater Capital Advisors, LLC | 32,894 | $1.1M | 0.1% | 0.7% | -9.4% |
| 16 | COMMONWEALTH EQUITY SERVICES, LLC | 27,651 | $933,210 | 0.0% | 0.6% | -0.1% |
| 17 | JONES FINANCIAL COMPANIES LLLP | 24,572 | $812,589 | 0.0% | 0.5% | +19.2% |
| 18 | Steward Partners Investment Advisory, LLC | 23,177 | $782,224 | 0.0% | 0.5% | -1.8% |
| 19 | Cambridge Investment Research Advisors, Inc. | 23,022 | $777 | 0.0% | 0.5% | +0.1% |
| 20 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLCNEW | 21,622 | $725,432 | 0.0% | 0.5% | new |
| 21 | CITADEL ADVISORS LLCNEW | 21,463 | $724,376 | 0.0% | 0.5% | new |
| 22 | ENVESTNET ASSET MANAGEMENT INC | 20,129 | $679,353 | 0.0% | 0.4% | +62.4% |
| 23 | GOLDMAN SACHS GROUP INC | 18,646 | $629,303 | 0.0% | 0.4% | +159.6% |
| 24 | C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors | 17,680 | $596,705 | 0.0% | 0.4% | -16.6% |
| 25 | PRUDENTIAL PLC | 16,800 | $567,000 | 0.0% | 0.4% | +4.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.